Home > Balance Sheet > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Deferred Tax Assets / Liabilities ₹101 Cr₹-142 Cr₹-300 Cr₹-422 Cr₹-433 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of TORRENT PHARMACEUTICALS ?

The latest Deferred Tax Assets / Liabilities ratio of TORRENT PHARMACEUTICALS is ₹101 Cr based on Mar2024 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2024₹101 Cr
Mar2023₹-142 Cr
Mar2022₹-300 Cr
Mar2021₹-422 Cr
Mar2020₹-433 Cr

How is Deferred Tax Assets / Liabilities of TORRENT PHARMACEUTICALS Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2024 ₹101 Cr
Positive
Mar2023 ₹-142 Cr
Negative
Mar2022 ₹-300 Cr
Negative
Mar2021 ₹-422 Cr
Negative
Mar2020 ₹-433 Cr -

Compare Deferred Tax Assets / Liabilities of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹101,909.2 Cr -5.6% -5.2% 18% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,003.0 Cr -1.6% -4.6% 14.7% Stock Analytics
DIVIS LABORATORIES ₹154,939.0 Cr -1.6% -1.3% 61.6% Stock Analytics
CIPLA ₹117,835.0 Cr 0.1% 1.2% 3.3% Stock Analytics
DR REDDYS LABORATORIES ₹99,787.0 Cr -2.1% -8.7% -2.3% Stock Analytics
ZYDUS LIFESCIENCES ₹90,722.1 Cr -6.5% -9.3% 8.6% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

-5.6%

-5.2%

18%

SENSEX

-2.5%

-1.4%

6.1%


You may also like the below Video Courses